Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Treatment-resistant depression: prevalence, risk factors, and treatment strategies.

Thase ME.

J Clin Psychiatry. 2011 May;72(5):e18. doi: 10.4088/JCP.8133tx4c.

2.

Update on partial response in depression.

Thase ME.

J Clin Psychiatry. 2009;70 Suppl 6:4-9. doi: 10.4088/JCP.8133su1c.01. Review.

3.

Achieving remission and managing relapse in depression.

Thase ME.

J Clin Psychiatry. 2003;64 Suppl 18:3-7.

4.
5.

Enhancing the efficacy of antidepressants with psychotherapy.

Petersen TJ.

J Psychopharmacol. 2006 May;20(3 Suppl):19-28. Review.

PMID:
16644768
6.

The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients.

Alexopoulos GS, Katz IR, Reynolds CF 3rd, Carpenter D, Docherty JP; Expert Consensus Panel for Pharmacotherapy of Depressive Disorders in Older Patients..

Postgrad Med. 2001 Oct;Spec No Pharmacotherapy:1-86.

PMID:
17205639
7.

Preventing relapse and recurrence of depression: a brief review of therapeutic options.

Thase ME.

CNS Spectr. 2006 Dec;11(12 Suppl 15):12-21. Review.

PMID:
17146414
8.

Psychotherapy and pharmacotherapy in depression.

Powers RH, Kniesner TJ, Croghan TW.

J Ment Health Policy Econ. 2002 Dec;5(4):153-61.

PMID:
14578549
9.

[Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].

Mouchabac S, Ferreri M, Cabanac F, Bitton M.

Encephale. 2003 Sep-Oct;29(5):438-44. French.

PMID:
14615693
10.

Rationale for, barriers to, and appropriate medication for the long-term treatment of depression.

Nutt DJ.

J Clin Psychiatry. 2010;71 Suppl E1:e02. doi: 10.4088/JCP.9058se1c.02gry.

11.
12.

Realistic expectations and a disease management model for depressed patients with persistent symptoms.

Keitner GI, Ryan CE, Solomon DA.

J Clin Psychiatry. 2006 Sep;67(9):1412-21. Review.

PMID:
17017828
13.

Pharmacotherapy of major depressive disorder in adolescents.

Masi G, Liboni F, Brovedani P.

Expert Opin Pharmacother. 2010 Feb;11(3):375-86. doi: 10.1517/14656560903527226. Review.

PMID:
20102303
14.

Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder.

Papakostas GI.

J Clin Psychiatry. 2009;70 Suppl 6:16-25. doi: 10.4088/JCP.8133su1c.03. Review.

15.

Major depressive disorder treatment guidelines in America and Europe.

Davidson JR.

J Clin Psychiatry. 2010;71 Suppl E1:e04. doi: 10.4088/JCP.9058se1c.04gry.

16.

What alternatives to first-line therapy for depression are effective?

Manning JS.

J Clin Psychiatry. 2010;71 Suppl 1:10-5. doi: 10.4088/JCP.9104su1c.02.

17.

Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE).

Rasmussen KG, Mueller M, Rummans TA, Husain MM, Petrides G, Knapp RG, Fink M, Sampson SM, Bailine SH, Kellner CH.

J Clin Psychiatry. 2009 Feb;70(2):232-7. Epub 2009 Jan 13.

PMID:
19192459
18.

Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder.

Perlis RH, Nierenberg AA, Alpert JE, Pava J, Matthews JD, Buchin J, Sickinger AH, Fava M.

J Clin Psychopharmacol. 2002 Oct;22(5):474-80.

PMID:
12352270
19.

Treatment-resistant depression.

Little A.

Am Fam Physician. 2009 Jul 15;80(2):167-72. Review.

20.

Exercise as an augmentation strategy for treatment of major depression.

Trivedi MH, Greer TL, Grannemann BD, Chambliss HO, Jordan AN.

J Psychiatr Pract. 2006 Jul;12(4):205-13.

PMID:
16883145

Supplemental Content

Support Center